Stay updated on PANAMO IFX-1 Clinical Trial
Sign up to get notified when there's something new on the PANAMO IFX-1 Clinical Trial page.
Latest updates to the PANAMO IFX-1 Clinical Trial page
- Check7 days agoChange DetectedThe screenshots show no changes to core content such as study title, conditions, eligibility criteria, primary or secondary outcomes, or location details; only minor layout and styling differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedCore content updated with a funding-operational status notice and a version bump to v3.2.0; removed the old v3.1.0 reference.SummaryDifference3%
- Check43 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.4%
- Check57 days agoChange DetectedPage revision bumped from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No substantive content changes detected.SummaryDifference0.2%
- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check72 days agoChange DetectedThe web page has been updated to include new drug information for vilobelimab and additional locations, while removing outdated references to COVID-19 topics and certain location terms.SummaryDifference8%
Stay in the know with updates to PANAMO IFX-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PANAMO IFX-1 Clinical Trial page.